Similar articles

• [Protease inhibitors and antifibrinolytic therapy].

  Manrique R. Manrique R. Arq Bras Cardiol. 1984 Nov;43(5):355-60. Arq Bras Cardiol. 1984. PMID: 6242229 Portuguese. No abstract available.
• Protease inhibitors in the treatment of hereditary angioedema.

  Ritchie BC. Ritchie BC. Transfus Apher Sci. 2003 Dec;29(3):259-67. doi: 10.1016/j.transci.2003.08.004. Transfus Apher Sci. 2003. PMID: 14572819 Review.
• [Principles and limitations in the use of protease inhibitors as antifibrinolytic agents].

  Markwardt F. Markwardt F. Folia Haematol Int Mag Klin Morphol Blutforsch. 1967;88(2):109-22. Folia Haematol Int Mag Klin Morphol Blutforsch. 1967. PMID: 4174648 German. No abstract available.
• [Preliminary report on the local treatment of joints with the protease-inhibitor Contrykal].

  Engler J. Engler J. Dtsch Gesundheitsw. 1969 Nov 13;24(46):2195-6. Dtsch Gesundheitsw. 1969. PMID: 5385553 German. No abstract available.
• [Creation of synthetic serine proteinase inhibitors, an important pharmacological problem].

  Markwardt F. Markwardt F. Farmakol Toksikol. 1978 Sep-Oct;41(5):530-3. Farmakol Toksikol. 1978. PMID: 359347 Review. Russian. No abstract available.